Treatment for opioid use disorder should remain connected when psychiatric care begins, changes, or moves to another setting. A hospital admission, residential stay, or new therapist should not leave an established medication plan without an owner. Before a transition, ask which clinician will continue prescribing, how the next supply or appointment is arranged, and how the receiving team will verify the current treatment.
The same principle works in the other direction: opioid treatment should not leave depression, PTSD, bipolar disorder, psychosis, or another mental health condition unattended. The goal is coordinated care for the person’s actual needs. This guide explains the handoff questions and common points of confusion without providing instructions for starting, stopping, or switching medicines.
Distinguish ongoing treatment from an isolated withdrawal episode
The CDC’s opioid use disorder treatment guidance identifies buprenorphine, methadone, and naltrexone as FDA-approved medication options. It also explains that detoxification alone, without medication treatment for opioid use disorder, is not recommended because of the risks of resumed use, overdose, and overdose death. An assessment should discuss ongoing treatment, not only how to get through withdrawal.
The medicines are not interchangeable, and the appropriate option depends on clinical assessment and the person’s preferences and circumstances. Ask the prescriber to explain the current choice and what it is intended to achieve. Do not move from one medicine to another because a program prefers a particular label or because someone else had a different experience.
If you are already benefiting from treatment, ask how it will continue while psychiatric needs are addressed. A statement that all medications must end before recovery can begin is not an adequate individualized explanation. The team should discuss benefits, risks, alternatives, and continuity using the actual clinical situation.
Verify the current plan before the move
The receiving clinician needs an accurate account of the medicine, formulation, prescribed instructions, recent administration or collection, and the responsible treatment service. Include any missed doses, interruptions, nonprescribed opioids, or other substances. These details affect assessment and should be verified through appropriate clinical channels rather than assumed from an old letter.
Our medication coordination guide explains how to reconcile records and actual use. If two records differ, ask a qualified professional to resolve the discrepancy. Do not decide independently that the higher, lower, or most recent-looking instruction is correct. The clinical team should explain the verified plan.
Obtain consent for the necessary exchange of information before the transition when possible. Identify who will contact the established prescriber or treatment program and who will confirm receipt. A list of phone numbers does not establish that the handoff has occurred. Ask whether the receiving service has actually accepted the relevant responsibility.
Confirm access at the destination
Ask whether the hospital, residential program, or community service can provide or coordinate the medication you need. What professional will prescribe or administer it, and which pharmacy or treatment service supplies it? Are there appointment or documentation requirements before the next planned treatment? Clarify the actual process rather than rely on a general claim that addiction care is available.
For a planned admission, resolve these questions before travel or payment where possible. The receiving team should know the established treatment and any current clinical concerns. If it cannot provide appropriate continuity, discuss another arrangement with the current clinician. Do not stop medication independently to meet an admission preference.
If the transition is urgent, tell the admitting team about opioid treatment immediately and provide the established service’s contact details. The team can assess the situation and obtain verification. A person in a psychiatric crisis may find it difficult to explain every detail, which makes a current record and a clear clinical contact especially useful.
Keep psychiatric prescribing informed
Tell the psychiatric clinician about opioid treatment and all other prescribed and nonprescribed substances. Ask how the combination will be assessed and monitored. Medicines used for sleep, anxiety, pain, and other conditions may require particular attention. The presence of several prescriptions should lead to coordinated review rather than separate decisions made from incomplete information.
The CDC’s 2022 opioid prescribing guideline states that buprenorphine or methadone for opioid use disorder should not be withheld solely because a patient takes benzodiazepines or other central nervous system depressants. It also emphasizes the risks of such combinations and the need for careful management. This is not reassurance that combining substances without medical oversight is safe.
Do not abruptly stop established medication or add borrowed sedatives to manage anxiety or sleep. Ask the relevant prescribers to agree a plan and explain any proposed change. If you receive conflicting instructions, request direct coordination. The patient should not become the person deciding which clinician’s advice to disregard.
Tell the team about planned surgery, dental treatment, or a new pain problem. The professionals managing the procedure need to know about opioid use disorder medication, and the addiction prescriber should be involved in planning where appropriate. Do not suspend treatment yourself because a procedure is approaching.
Pain still deserves assessment and an appropriate treatment plan. Ask who will coordinate the immediate pain care with ongoing opioid and psychiatric treatment, including after discharge. The discussion should produce clear instructions rather than leave you choosing between untreated pain and an unreviewed medication change.
Make behavioral and practical support available without creating a barrier
Counseling, psychiatric treatment, and social support may have important roles alongside opioid medication. The CDC guidance also notes that declining psychosocial treatment, or its unavailability, should not preclude or delay medication treatment for opioid use disorder. Ask the service how it maintains access while helping you find appropriate additional support.
Our shared care plan guide helps identify the purpose of each component. A therapist may address PTSD or mood symptoms, an addiction clinician may manage medication, and a case manager may help with appointments or housing. The roles should connect without making participation in every possible activity a condition for all care.
Practical barriers deserve a direct response. Transportation, opening hours, caregiving, work, fees, or a pharmacy problem can interrupt treatment despite willingness to continue. Tell the team about the barrier early and ask who can help resolve it. Repeating advice to attend does not solve an arrangement that is inaccessible.
Plan for interruptions rather than improvising
Ask what to do if an appointment is missed, a medicine is unavailable, or a discharge is delayed. The correct response depends on the specific treatment and circumstances. Do not take extra medication to compensate, restart from an old instruction, or borrow a supply. Contact the responsible clinician or service promptly for individualized advice.
If opioid use occurs during an interruption, tell the team. They need to assess overdose risk, current symptoms, and the next treatment step. Avoid treating shame or fear of a program response as a reason to conceal information needed for safety. A revised plan should address the interruption as well as the episode of use.
For travel, confirm the clinical and official medicine requirements for the destination and any transit location. Availability, prescribing arrangements, and transport rules can differ. Begin the discussion early with the treatment service and appropriate authorities. A prescription that is valid at home does not by itself answer every question about treatment abroad.
Include overdose prevention and urgent contacts
Ask the team about naloxone and training for you and, with appropriate agreement, people likely to be present in an emergency. CDC recommends offering naloxone and education to people with opioid use disorder and their household members or significant others. Naloxone is used for suspected opioid overdose; it is different from naltrexone, which may be prescribed as part of ongoing treatment.
If someone cannot be awakened, has very slow or abnormal breathing, or may be experiencing an overdose, call emergency services immediately. Use naloxone if available according to its instructions and follow emergency guidance. Do not wait for a routine clinic to open or assume the person can simply sleep it off. Other substances may also be involved.
The shared plan should also identify urgent psychiatric support. Severe confusion, a major change in mental state, or immediate self-harm danger needs prompt assessment. A medication refill contact and a crisis service have different functions. Make sure you know the appropriate route for each situation.
Review continuity after discharge
Before leaving a service, confirm the next clinical appointment and how medication will remain available until then under the agreed plan. Ask who is responsible for monitoring, laboratory results if relevant, and communication with the psychiatric clinician. A referral recommendation is not the same as an appointment that has been accepted and arranged.
At follow-up, discuss cravings, opioid use, medication benefit and problems, mental health symptoms, and daily functioning. Improvement in one area can coexist with difficulty in another. The team should review both rather than assume that continued medication alone resolves every need or that psychiatric progress means opioid care can be discontinued.
If a change in treatment is proposed, ask for the clinical rationale, alternatives, monitoring, and continuation plan. The objective is appropriate care over time, with decisions based on benefits and risks. A successful transition leaves you knowing who is responsible, what happens next, and how to obtain help before another gap develops.
Sources and further reading
Found a detail that has changed? Tell the editorial team.